These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 9783885

  • 1. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G, Stuschke M, Knühmann K, Horsman MR, Sack H.
    Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
    [Abstract] [Full Text] [Related]

  • 2. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ, Horsman MR, Siemann DW.
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [Abstract] [Full Text] [Related]

  • 3. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR, Overgaard J.
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [Abstract] [Full Text] [Related]

  • 4. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW, Horsman MR, Chaplin DJ.
    Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
    [Abstract] [Full Text] [Related]

  • 5. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J.
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [Abstract] [Full Text] [Related]

  • 6. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van Daal WA, van der Kogel AJ.
    Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
    [Abstract] [Full Text] [Related]

  • 7. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
    Horsman MR, Nordsmark M, Khalil AA, Hill SA, Chaplin DJ, Siemann DW, Overgaard J.
    Acta Oncol; 1994 Aug; 33(4):371-6. PubMed ID: 8018368
    [Abstract] [Full Text] [Related]

  • 8. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K, Masunaga S, Akuta K, Akaboshi M, Abe M.
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y, Lam GK, Pickles T, Fryer C, Chaplin DJ.
    Radiat Med; 1995 Aug; 13(6):291-5. PubMed ID: 8850370
    [Abstract] [Full Text] [Related]

  • 10. Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study.
    Hulshof MC, Rehmann CJ, Booij J, van Royen EA, Bosch DA, González González D.
    Radiother Oncol; 1998 Aug; 48(2):135-42. PubMed ID: 9783884
    [Abstract] [Full Text] [Related]

  • 11. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
    Fatigante L, Ducci F, Cartei F, Colosimo S, Marini C, Prediletto R, Danesi R, Laddaga M, Del Tacca M, Caciagli P.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):499-504. PubMed ID: 9112444
    [Abstract] [Full Text] [Related]

  • 12. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
    Honess DJ, Hill SA, Collingridge DR, Edwards B, Brauers G, Powell NA, Chaplin DJ.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):731-5. PubMed ID: 9845086
    [Abstract] [Full Text] [Related]

  • 13. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
    Sun LQ, Coucke PA, Mirimanoff RO, Buchegger F.
    Radiat Res; 2001 Jan 01; 155(1 Pt 1):26-31. PubMed ID: 11121212
    [Abstract] [Full Text] [Related]

  • 14. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
    Simon JM, Noël G, Chiras J, Hoang-Xuan K, Delattre JY, Baillet F, Mazeron JJ.
    Radiother Oncol; 2003 Apr 01; 67(1):45-51. PubMed ID: 12758239
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A, Menke D, Dorie MJ, Brown JM.
    Radiat Oncol Investig; 1999 Apr 01; 7(3):163-9. PubMed ID: 10406058
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
    Bussink J, Kaanders JH, Van der Kogel AJ.
    Acta Oncol; 1999 Apr 01; 38(7):875-82. PubMed ID: 10606417
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 18. Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy.
    Wittenborn TR, Horsman MR.
    Acta Oncol; 2015 Jan 01; 54(9):1385-92. PubMed ID: 26329662
    [Abstract] [Full Text] [Related]

  • 19. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing.
    Grau C, Horsman MR, Overgaard J.
    Int J Radiat Oncol Biol Phys; 1992 Jan 01; 22(3):415-9. PubMed ID: 1735671
    [Abstract] [Full Text] [Related]

  • 20. Tumour oxygenation during fractionated radiotherapy--comparison with size-matched controls.
    Stüben G, Thews O, Pöttgen C, Stuschke M, Sack H.
    Acta Oncol; 1999 Jan 01; 38(2):209-13. PubMed ID: 10227443
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.